In 2023, the total internal R&D personnel in human health activities in the UK stood at a certain baseline before witnessing forecasted increases over the next five years. From 2024 to 2028, the forecast indicates a steady year-on-year percentage growth, suggesting a robust and sustained investment in human health R&D. By 2028, personnel numbers are expected to reach 865.42 in full-time equivalent, indicating healthy growth within the sector.
Year-on-Year Variations:
- 2024 to 2025: Approximately 3.93% growth
- 2025 to 2026: Approximately 3.71% growth
- 2026 to 2027: Approximately 3.51% growth
- 2027 to 2028: Approximately 3.32% growth
Five-year CAGR: With these numbers, the Compound Annual Growth Rate from 2024 to 2028 stands at a consistent upward trend, showcasing an average annual growth rate.
Looking ahead, companies should focus on fostering technological innovation, adapting to regulatory changes, and maintaining skilled workforce retention to ensure the continuous upward trajectory of R&D personnel. Monitoring geopolitical factors and funding landscapes will be vital for future growth in this sector.
